The Double Blind Method
The gist of Costello's argument (I) is that only clinical observations of a specific kind, that 'is double blind, constitute science in medicine. Thus he writes "To adopt such an attitude would be to retreat from the position of medicine as a scientifically based practice to a dependence on clinical authority.' , All other clinical observations no matter how carefully made are presumably not scientific. This is an interesting proposition which in itself has not been established by controlled experiments. I have been unable to find a single study or report in which it has been established on a scientific basis that the double blind really accomplishes what it is hoped it will doincrease accuracy in determining efficacy of treatment. I ask Dr. Costello to cite the studies which have established double blinds empirically.
Any method used in science, for example measuring blood pressure, will not be accepted until it has been compared with a previous or standard method. It must first be calibrated. If, as a result of such a comparison, it is shown that the newer method is as accurate or more accurate (less variable) and has other advantages it will supersede the older one and become the standard method.
The double-blind method has never been calibrated. It swept into power because it promised to ease the burden of governments in deciding which drugs should be released as efficacious. It was assumed that since double blinds often found drugs to be no more efficacious than placebo that it was superior to the usual methods. It did not occur to the promoters of this technique that one could as well conclude that any method which showed active drugs (as seen by many clinicians) to be inactive must be a dud method.
The whole question of the numerous errors arising from double blinds and inherent in it are discussed in Nailing the Lies (2).
Costello has the right to conclude that only double blinds are scientific but his opinion is not shared by a large number of scientists and clinicians. In my opinion double blinds are merely one technique for trying to measure efficacy. It is expensive, difficult to run, seldom achieves true double-blind status and is unreliable. It has a very limited use only. To apply it to a procedure such as ECT is impossible. Any observer, nurse or doctor who fails to note the obvious confusion which is present after a series of ECT would be an unreliable observer whether the experiment were double blind, or single blind. The basis of any science is accurate observations. Even reading a meter requires that one can see.
A The Double Blind Method Doctor Hoffer is confused. And this is most clearly revealed in the sentence •'The double-blind method has' never been calibrated." This is correct-s-it has not. Furthermore, it never will be because the double-blind method is not an instrument of measurement, the gradations of which are in question. The term 'double blind' refers to the conditions under which treatments are administered and/or the effects of the treatments are measured.
Doctor Hoffer has chosen to concentrate, with somewhat inadequate focusing, on the conditions of measurement. Therefore, it is in relation to measurement first of all that I shall briefly state again the case for double-blind procedures. The phenomena to be measured in psychiatry usually involve subjective evaluations on the part of the patient and/or an observer. For instance, a patient may be required to answer questions concerning his feelings of depression, anxiety, guilt and so on. If, after treatment, he reports a lesser intensity of such feelings, it may very well be because he wants to believe he feels better or wants the doctor to believe it. His reports are much more under his volitional control than is his blood pressure-at least at this early stage of our biofeedback skills. A physician's judgment of his patient's condition may be biased in a similar manner.
The double-blind method, along with placebos, is also used in an attempt to control for the effects of patient and therapist expectancies This is not the place to go into the variety of possible results and the most plausible inferences that could be made. In any case, they will be obvious to the reader.
To go back to the measurement problem, clinical observations cannot be considered scientific observations. They are simply too private. Doctor Hoffer may prefer to give more weight to clinical observations. They are not the only ones to look askance at science. Much of the activism of the student rebels in the late 1960's involved Luddite-like attacks on science. I prefer to stay with science for the moment. On the other hand, it would be better if our technologies-ECT, medications, electric shock in behaviour modification did not run so far ahead of our scientific understanding of the neurological, biochemical and psychological aspects of emotional disorders. But then perhaps there is too much Irishness in me and I am like the Irishman who was not that impressed when he first saw the steam engine, remarking, "I can see it works in practice all right. But does it work in theory." Charles G. Costello Ph.D.. Calgary Alta.
The double-blind method is not a dud method. It is a too simple one. It cannot be calibrated and cannot (no more say than the method of analysis of variance) be empirically tested. The use of the term should probably be abandoned (not swept out of power) and we should recognize that the variable of awareness should be manipulated rather than controlled. We would then ask of any study if awareness had been manipulated rather than if it had been double-blind. Ignoring differences between patient and therapist awareness, the usual type of design would then be as indicated below: on changes in the patient's condition. Let us suppose that in the double-blind placebocontrolled experiment the treatment effect is no greater than the effect of the placebo, and both are less than the effects of treatment in uncontrolled studies. Such a finding strongly suggests that the treatment effect in the uncontrolled studies has nothing to do with the specific properties of the treatment itself but results from the general psychological effects of receiving help from someone and/or from the impact made by the confidence and enthusiasm of the therapist.
But of course the treatment effect and the placebo effect may not be equal in the controlled study, and either one or both may produce greater or lesser effects than treatment in uncontrolled studies. This important point is one that Hoffer and his colleague Osmond have made repeatedly but the message has probably got lost because of confusion in terminology as when they write about calibrating the doubleblind method or the politicizing of the issue. To write of the double-blind method that "It swept into power" and that it is not superior to the view of " ... many clinicians" is to make a tyrannical Amin out of the method and a struggling proletariat out of the clinicians.
The scientific point is that the double-blind method simply tries to control for the effects of patient and therapist expectancies by reducing to zero their awareness of whether or not treatment is being or has been administered. This condition of unawareness, with the inevitable insecurity on the part of both the patient and the therapist, may not only remove the seeming beneficial effect of treatment observed clinically but may result in a worsening of the patient's condition. Hoffer and Osmond have suggested that the word placebo be reversed and 'obecalp' be the term to describe this detrimental effect of the double-blind condition. This is not a particularly helpful word and if a word must be used' displacebo' would be a better one. 
